Product Information
HOWARU® Protect Baby
1B CFU | HOWARU® Lactiplantibacillus plantarum Lp202195 + 150 mg Fructooligosaccharide (FOS)
Health Benefits:
Early Life Development
Immune Health
The distinctive strain within HOWARU® Protect Baby is well-documented, proven safe and backed by robust clinical trials – including one of the largest clinical trials of infants to date.
Altogether, the combination of L. plantarum ATCC- 202195 plus the prebiotic FOS has been shown to provide significant immune and digestive health benefits in infants, after just seven days of supplementation.
Download the handout to learn more.
• Provides immune support for infants
• Supports baby’s gut and immune system development
• Promotes increased levels of healthy
L. plantarum ATCC-202195*, the strain in HOWARU® Protect Baby, and fructo-oligosaccharide (FOS) were investigated for their effects to prevent severe infections in neonatal infants in a randomized, double-blind, placebo-controlled clinical trial with 4,556 healthy newborns.
Infants received oral supplementation of 1B CFU of L. plantarum – and 150 mg of FOS – daily for seven days, starting on the second to fourth day of life; participants were monitored daily for over 60 days.
Researchers found that the synbiotic supplementation was associated with statistically significant reduced risk of sepsis by 42% (p<0.001), lower respiratory tract infection by 34% (p=0.002) and diarrhea by 80% (p<0.001).
References: Panigrahi et al,. 2008; Panigrahi, P., et al,. 2017; Chandel DS et al., 2017.
We’d love to talk to you about how our microbiome and bioscience expertise can help you develop, manufacture and deliver solutions that enable people at all life stages to live healthier and happier lives.